ВестникНОМУС
.
Сборникматериалов
конкурса
литературных
обзоров
-2012
175
7. Barnhart K et al. Return to fertility after cessation of a continuous oral
contraceptive. Fertil Steril 2009; 91 (5): 1654–6.
8. Barros RP, Machado UF, Gustafsson JA. Estrogen receptors: new players in
diabetesmellitus. TrendsMolMed2006; 12 (9): 425–31.
9. Beral V et al. Ovarian cancer and oral contraceptives: collaborative reanalysis of
data from 45 epidemiological studies including 23,257 women with ovarian cancer
and 87,303 controls. Lancet 2008; 371 (9609): 303–14.
10. Bosetti C et al. Oral contraceptives and colorectal cancer risk: a systematic review
andmeta-analysis. HumanReproductionUpdate 2009; 15 (5): 489–98.
11. Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits
associatedwith oral contraception. Am JObstet Gynecol 2004; (Suppl. 4), 190: 5–22.
12. Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY. Hormone replacement
therapy and risk of venous thromboembolism in postmenopausal women: systematic
review andmeta-analysis.
BMJ. 2008May31;336(7655):1227-31. Epub 2008May20.
13. Cibula1D., Gompel A. Hormonal contraception and risk of cancer. Hum. Reprod.
Update (2010) 16 (6): 631-650.
14. Davison S, Davis SR. New markers for cardiovascular disease risk in women:
impact of endogenous estrogen status and exogenous postmenopausal hormone
therapy. JClinEndocrinolMetab2003; 88 (6): 2470–8.
15. Eleanor Bimla Schwarz, Rachel Hess, Contraception for Cancer Survivors. J Gen
InternMed. 2009November; 24(Suppl 2): 401–406.
16. ESHRECapriWorkshopGroup. Hormones and cardiovascular health inwomen.
HumReprodUpdate 2006; 12 (5): 483–97.
17. FarrowA, HullMGR et al. Prolonged use of oral contraception before a planned
pregnancy is associated with a decreased risk of delayed conception. Human
Reproduction 2002; 17 (10): 2754–61.
18. Fernandez E et al. Oral contraceptives and colorectal cancer risk: ameta-analysis.
Br JCancer 2001; 84 (5): 722–7.
19. GalloMF, Grimes DA, ShulzKF, Helmerhorst FM. Combination contraceptives:
effects onweight. CohraneDatabaseSyst Rev2003; 2: CD003987.
20. Han G, Ma H, Chintala R et al. Essential role of the 90-kilodalton heat shock
protein in mediating nongenomic estrogen signaling in coronary artery smooth
muscle. J Pharmacol ExpTher 2009; 329 (3): 850–5.
